National Health Investors (NYSE:NHI) CEO D. Eric Mendelsohn Purchases 1,500 Shares of Company Stock

National Health Investors, Inc. (NYSE:NHI – Get Free Report) CEO D. Eric Mendelsohn purchased 1,500 shares of the business’s stock in a transaction dated Tuesday, November 17th. The shares were purchased at an average price of $60.53 per share, for a total transaction of $90,795.00. Following the purchase, the chief executive officer owned 134,816 shares of the company’s stock, valued at approximately $8,160,412.48. This trade represents a 1.13% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink.

National Health Investors Stock Performance

NHI stock opened at $62.41 on Thursday. The company has a debt-to-equity ratio of 0.50, a current ratio of 13.59 and a quick ratio of 13.59. The business has a 50-day moving average price of $66.73 and a 200 day moving average price of $75.57. The company has a market capitalization of $3.06 billion, a P/E ratio of 4.38, a PEG ratio of 3.86 and a beta of 0.51. National Health Investors, Inc. has a 1-year low of $59.05 and a 1-year high of $91.38.

National Health Investors (NYSE:NHI – Get Free Report) last issued its earnings results on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.18 by $10.29. The company had revenue of $113.48 million for the quarter, compared to analysts’ expectations of $68.53 million. National Health Investors had a net margin of 152.82% and a return on equity of 41.41%. As a group, equities research analysts forecast that National Health Investors, Inc. will post 4.72 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 5.9%. The ex-dividend date of this dividend is Thursday, December 31st. National Health Investors’s dividend payout ratio is presently 26.40%.

Institutional Investors Weigh In On National Health Investors

A number of hedge funds and other institutional investors have recently bought and sold shares of NHI. BlackRock Inc. acquired a new stake in National Health Investors in the second quarter valued at approximately $665,997,000. Bank of New York Mellon Corp purchased a new position in National Health Investors in the second quarter worth $122,509,000. Bank of America Corp DE increased its position in shares of National Health Investors by 20.0% during the first quarter. Bank of America Corp DE now owns 992,802 shares of the real estate investment trust’s stock worth $80,278,000 after purchasing an additional 165,467 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of National Health Investors by 2.7% during the first quarter. Dimensional Fund Advisors LP now owns 686,249 shares of the real estate investment trust’s stock worth $55,493,000 after purchasing an additional 18,164 shares in the last quarter. Finally, Legal & General Group Plc acquired a new position in shares of National Health Investors during the second quarter worth $21,745,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on NHI shares. Zacks Research raised shares of National Health Investors from a “strong sell” rating to a “hold” rating in a report on Tuesday, September 29th. Wells Fargo & Company reduced their price objective on shares of National Health Investors from $68.00 to $65.00 and set an “equal weight” rating for the company in a research note on Monday. Bank of America lowered National Health Investors from a “buy” rating to an “underperform” rating and lowered their target price for the stock from $86.00 to $67.00 in a report on Friday, November 13th. Weiss Ratings cut National Health Investors from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday. Finally, BMO Capital Markets reiterated an “outperform” rating on shares of National Health Investors in a report on Wednesday, September 23rd. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $79.11.

View Our Latest Research Report on National Health Investors

About National Health Investors

(Get Free Report)

National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee. NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans. The company serves markets across the United States.

Featured Articles

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.